The 16th Annual Pharmacogenetics in Psychiatry Meeting
Loews Sapphire Falls Resort, Orlando, Florida
October 12, 2017
The 16th Annual Pharmacogenetics in Psychiatry Meeting was held in conjunction with the XXVth World Congress of Psychiatric Genetics on October 12th.
The annual Pharmacogenetics in Psychiatry meeting provided a forum for the presentation and discussion of new developments in the rapidly developing field of psychiatric pharmacogenetics. Previous meetings have been highlighted by discussion of topics including: prediction of clinical response to antipsychotic drugs, genes associated with the development of adverse side effects, candidate gene and genome-wide association (GWAS) studies of antidepressant response, the identification of new polymorphisms influencing gene product function, and novel statistical approaches to dissect the heterogeneity of drug response. Moreover, we have brought together investigators working in diverse areas of psychiatric research, from molecular geneticists to clinical trial investigators, from academia and industry, in order to engender true interdisciplinary approaches to the problem of variation in clinical response to psychotropic drugs.